BCR and B-cell chronic lymphocytic leukemia: The dynamic loss and gain of BCR clonotypes as well as SNV-defined subclones could be indicative of differences in the selection pressure mediated by the tumor microenvironment, including the strength of antitumor immune responses during the course of CLL.